Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

E. A. Piercy, D. Barbaro, J. P. Luby, P. A. Mackowiak

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

Thirty-seven patients with meticillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

Original languageEnglish (US)
Pages (from-to)128-130
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume33
Issue number1
DOIs
StatePublished - 1989

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections'. Together they form a unique fingerprint.

Cite this